"You want some Midkine Potential, MJ"
That would be fantastic pharma. My reason for investing in CDY was because of their large pipeline of patents in midkine but we seem to have shifted focus to consumer health (and I believe we are doing it quite successfully).However I hope we don't lose sight of the value in the midkine portfolio. Your $34mil potential income makes last year's Licence Fees and Royalties of $62,252 look insignificant but I am an optimist and looking forward to our NZ cousins achieving success in the USA and elsewhere.
CDY Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
